3 Biopharmaceuticals Weighed by Uncertainty

Published December 8, 2012

3 Biopharmaceuticals Weighed By Uncertainty

Filed under: drug treatment news articles

I have no business relationship with any company whose stock is mentioned in this article. (More…) The American Journal of … Shares of anti-obesity drug makers received a major stimulus after the third largest health insurer in the United States …
Read more on Seeking Alpha

NPS Pharma Drifts Higher On Potential Orphan Drug Approval

Filed under: drug treatment news articles

As mentioned earlier, NATPARA's orphan drug designation gives it 7 (instead of 5) years of drug exclusivity in the United States and also gives it some extra pricing power due to the lack of treatment options at this time. NPSP has been advancing quite …
Read more on Seeking Alpha

After Two Drug Approvals, Can Supernus Deliver In 2013?

Filed under: drug treatment news articles

Trokendi XRTM, is a novel, oral, extended-release, once-daily formulation of topiramate for the treatment of epilepsy. The drug received tentative approval from the FDA in June 2012. Trokendi XRTM delivers topiramate, one of the most effective …
Read more on Seeking Alpha